Current Neuro-Oncology
Volume
25 Number 5
15 March 2023
Home > Publications > Current Neuro-Oncology > Volume 25, Year 2023 > Number 5, 15 March
Królicki
L, Kunikowska J, Bruchertseifer F, Kuliński R, Pawlak D,
Koziara H, Rola R, Morgenstern A, Merlo A.
Locoregional
Treatment of Glioblastoma With Targeted α Therapy:
[213Bi]Bi-DOTA-Substance P Versus [225Ac]Ac-DOTA-Substance
P-Analysis of Influence Parameters.
Clin
Nucl Med. 2023 Mar 1∟.
doi: 10.1097/RLU.0000000000004608∟.
PMID: 36854309∟.
Observational study˰ ˍ
*
Nematollahi-Mahani SN, Ganjalikhan-Hakemi S, Abdi Z.
The
Regression of Glioblastoma Multiforme is Time Dependent in the
Wild-type Rat Xenograft Model.
Basic Clin Neurosci.
2023 Mar 1;14(2):263-272∟. doi: 10.32598/bcn.2021.3370.1∟.
PMID: 38107534∟. Laboratory investigation. ˍ
Bergengruen
PM, Hernaíz Driever P, Budach V, Zips D, Grün
A.
Second
course of re-irradiation in pediatric diffuse intrinsic pontine
glioma : A case study.
Strahlenther
Onkol. 2023 Mar 2∟.
doi: 10.1007/s00066-023-02057-x∟.
PMID: 36862153∟.
Case report. ˍ
Kaisman-Elbaz
T, Xiao T, Grabowski MM, Barnett GH, Mohammadi AM.
The
Impact of Extent of Ablation on Survival of Patients With Newly
Diagnosed Glioblastoma Treated With Laser Interstitial Thermal
Therapy: A Large Single-Institutional Cohort.
Neurosurgery.
2023 Mar 2∟.
doi: 10.1227/neu.0000000000002430∟.
PMID: 36861990∟.
Observational study˰ ˍ
Riviere-Cazaux C, Lacey JM, Carlstrom LP, Laxen WJ,
Munoz-Casabella A, Hoplin MD, Ikram S, Zubair AB, Andersen KM,
Warrington AE, Decker PA, Kaufmann TJ, Campian JL, Eckel-Passow
JE, Kizilbash SH, Tortorelli S, Burns TC.
Cerebrospinal
fluid 2-hydroxyglutarate (2-HG) as a monitoring biomarker for
IDH-mutant gliomas.
medRxiv
[Preprint]. 2023 Mar 2:2023.03.01.23286412∟.
doi: 10.1101/2023.03.01.23286412∟.
PMID: 36909488∟.
Laboratory investigation. ˍ
Said MM, Broen MPG, Swart EL, Bartelink IH, Kouwenhoven
MCM.
Myelotoxicity of Temozolomide
Treatment in Patients with Glioblastoma Is It Time for a More
Mechanistic Approach?
Cancers (Basel). 2023 Mar
2;15(5):1561∟.
doi: 10.3390/cancers15051561∟.
PMID: 36900352∟.
Editorial. ˍ
Zhang W, Jiang J, Kang X, Wang C, Chen F, Zhang B, Li S, Huang S,
Li W.
Dietary B vitamins and glioma: A
case-control study based on Chinese population.
Front
Nutr. 2023 Mar 2;10:1122540∟.
doi: 10.3389/fnut.2023.1122540∟.
PMID: 36937346∟.
Observational study. ˍ
Zhang W, He Y, Kang X, Wang C, Chen F, Kang Z, Yang S, Zhang R,
Peng Y, Li W.
Association between
dietary minerals and glioma: A case-control study based on Chinese
population.
Front Nutr.
2023 Mar 2;10:1118997∟.
doi: 10.3389/fnut.2023.1118997∟.
PMID: 36937365∟.
Observational study. ˍ
Azad TD,
Kalluri AL, Hansen LJ, Ammar A, Cohen AR.
H3
K27-altered diffuse midline glioma presenting as massive
cerebellopontine hemorrhage.
Childs
Nerv Syst. 2023 Mar 3∟.
doi: 10.1007/s00381-023-05904-5∟.
PMID: 36867241∟.
Case report˰ ˍ
Gong M, Fan
X, Yu H, Niu W, Sun S, Wang H, Chen X.
Loss
of p53 Concurrent with RAS and TERT Activation Induces Glioma
Formation.
Mol
Neurobiol. 2023 Mar 3∟.
doi: 10.1007/s12035-023-03288-w∟.
PMID: 36867344∟.
Laboratory investigation˰ ˍ
Schmidt S,
Kovacs E, Usta D, Behnisch R, Sahm F, Haux D, Witt O, Milde T,
Unterberg A, El Damaty A.
Cerebellar
mutism syndrome following posterior fossa tumor surgery in
children - a retrospective single center study.
World
Neurosurg. 2023 Mar 3:S1878-8750(23)00268-1∟.
doi: 10.1016/j.wneu.2023.02.117∟.
PMID: 36871657∟.
Observational study˰ ˍ
Silva JA, Colquhoun A.
Effect of
Polyunsaturated Fatty Acids on Temozolomide Drug-Sensitive and
Drug-Resistant Glioblastoma Cells.
Biomedicines.
2023 Mar 4;11(3):779∟.
doi: 10.3390/biomedicines11030779∟.
PMID: 36979758∟.
Laboratory
investigation. ˍ
Yao J, Li S, Cui Q, Ren Y, Li M, Wang J, Zeng M, Ji N, Peng Y,
Sessler DI.
Intraoperative hypotension
and postoperative stroke in older patients who had brain tumour
resections: a retrospective cohort analysis.
World
Neurosurg. 2023 Mar 4:S1878-8750(23)00284-X∟.
doi: 10.1016/j.wneu.2023.02.136∟.
PMID: 36878404∟.
Observational study˰ ˍ
Łach K, Kowal A, Perek-Polnik M, Jakubczyk P, Arthur CJ, Bal
W, Drogosiewicz M, Dembowska-Bagińska B, Grajkowska W,
Cebulski J, Chaber R.
Infrared
Spectroscopy as a Potential Diagnostic Tool for
Medulloblastoma.
Molecules.
2023 Mar 5;28(5):2390∟.
doi: 10.3390/molecules28052390∟.
PMID: 36903631∟.
Observational study. ˍ
*
Stoyanov GS, Petkova L, Iliev B, Ali M, Toncheva B, Georgiev R,
Tonchev T, Enchev Y.
Extracranial
Glioblastoma Metastasis: A Neuropathological Case Report.
Cureus.
2023 Mar 5;15(3):e35803∟.
doi: 10.7759/cureus.35803∟.
PMID: 37025749∟.
Case report. ˍ
Henriksen KA, Von Oettingen G, Skjøth-Rasmussen J,
Mathiasen R, Foss-Skiftesvik J.
Assessment
of the Milan Complexity Scale for prediction of postoperative
morbidity in pediatric neuro-oncological surgery.
Childs
Nerv Syst. 2023 Mar 6∟.
doi: 10.1007/s00381-023-05902-7∟.
PMID: 36877208∟.
Observational study˰ ˍ
Jatana S, Mohammad AH, Al-Saadi TD, Carias M, Guevara-Moriones N,
Ruiz-Barrera MA, Mindru CS, Diaz RJ.
Characterization
of perioperative glycemic status and dexamethasone use with
associated postoperative complications in glioblastoma
patients.
Acta
Neurochir (Wien). 2023 Mar 6∟.
doi: 10.1007/s00701-023-05541-6∟.
PMID: 36879101∟.
Observational study˰ ˍ
More S, Naiker T, Jacobs N, Oompie F, Prasad V.
Short-Interval,
Low-Dose [177Lu]Lu-Prostate-Specific Membrane Antigen in the
Treatment of Refractory Glioblastoma.
Clin
Nucl Med. 2023 Mar 6∟.
doi: 10.1097/RLU.0000000000004612∟.
PMID: 36881610∟.
Case report˰ ˍ
Trifiletti DM, Akinyelu T, Burri SH, Jeudy A, Quinones-Hinojosa A,
Prabhu RS.
Glioma inadvertently treated
with preoperative stereotactic radiosurgery: focusing on safety.
J
Neurooncol. 2023 Mar 6∟.
doi: 10.1007/s11060-023-04278-7∟.
PMID: 36877383∟.
Case report˰ ˍ
Ajuyah P, Mayoh C, Lau LMS, Barahona P, Wong M, Chambers H,
Valdes-Mora F, Senapati A, Gifford AJ, D'Arcy C, Hansford JR,
Manoharan N, Nicholls W, Williams MM, Wood PJ, Cowley MJ, Tyrrell
V, Haber M, Ekert PG, Ziegler DS, Khuong-Quang DA.
Histone
H3-wild type diffuse midline gliomas with H3K27me3 loss are a
distinct entity with exclusive EGFR or ACVR1 mutation and
differential methylation of homeobox genes.
Sci
Rep. 2023 Mar 7;13(1):3775∟.
doi: 10.1038/s41598-023-30395-4∟.
PMID: 36882456∟.
Case report, Interventional study. ˍ
Friker LL, Tzaridis T, Enkirch SJ, Lüders C, Hattingen E,
Kristiansen G, Goschzik T, Waha A, Lütter C, Weller J,
Herrlinger U, Pietsch T, Gessi M, Baumert BG, Gielen
GH.
Gliosarcoma with extensive
extracranial metastatic spread and familial coincidence: A case
report.
Pathol
Res Pract. 2023 Mar 7;244:154399∟.
doi: 10.1016/j.prp.2023.154399∟.
PMID: 36905695∟.
Case report˰ ˍ
Kaneoka A, Fujimoto SH, Tamura K, Inaji M, Maehara
T.
Nonconvulsive status epilepticus
characteristics in glioma patients: a retrospective study.
Discov
Oncol. 2023 Mar 7;14(1):30∟.
doi: 10.1007/s12672-023-00632-3∟.
PMID: 36881187∟.
Observational
study. ˍ
Pace A, Belleudi V, Tanzilli A, Villani V, Poggi FR, Benincasa D,
Davoli M, Pinnarelli L.
Pattern of care
of brain tumor patients in the last months of life: analysis of a
cohort of 3045 patients in the last 10 years.
Neurol
Sci. 2023 Mar 7∟.
doi: 10.1007/s10072-023-06722-y∟.
PMID: 36882595∟.
Observational study˰ ˍ
Kang Z, Li S, Lin Y, Li Y, Mao Y, Zhang J, Lei T, Wang H, Su Y,
Yang Y, Qiu J, Li W.
A phase I
dose-escalation study of SYHA1813, a VEGFR and CSF1R inhibitor, in
patients with recurrent High-Grade Gliomas or Advanced Solid
Tumors.
Invest
New Drugs. 2023 Mar 8∟.
doi: 10.1007/s10637-022-01325-4∟.
PMID: 36884148∟.
Interventional study. ˍ
*
Ermiş E, Althaus A, Blatti M, Uysal E, Leiser D, Norouzi S,
Riggenbach E, Hemmatazad H, Ahmadli U, Wagner F.
Therapy
Resistance of Glioblastoma in Relation to the Subventricular Zone:
What Is the Role of Radiotherapy?
Cancers
(Basel). 2023 Mar 9;15(6):1677∟.
doi: 10.3390/cancers15061677∟.
PMID: 36980563∟.
Observational study. ˍ
Huang V, Rejimon A, Reddy K, Trivedi AG, Ramesh KK, Giuffrida AS,
Muiruri R, Shim H, Eaton BR.
Spectroscopic
MRI-Guided Proton Therapy in Non-Enhancing Pediatric High-Grade
Glioma.
Tomography.
2023 Mar 9;9(2):633-646∟.
doi: 10.3390/tomography9020051∟.
PMID: 36961010∟.
Observational
study. ˍ
Valvi S, Dun MD, Hansford JR.
National
brain tumour registry: a new era of research collaboration with
China.
Lancet Reg
Health West Pac. 2023 Mar 9;34:100739∟.
doi: 10.1016/j.lanwpc.2023.100739∟.
PMID: 37283976∟.
Comment. ˍ
REFERS
TO:
Xiao D, et al., National
Brain Tumour Registry of China (NBTRC) statistical report of
primary brain tumours diagnosed in China in years 2019-2020.
Lancet Reg
Health West Pac. 2023 Feb 21;34:100715∟.
doi: 10.1016/j.lanwpc.2023.100715∟.
PMID: 37283963∟.
Observational study. ˍ
Champeaux-Depond C, Jecko V, Weller J, Constantinou P, Tuppin P,
Metellus P.
Newly-diagnosed high grade
glioma surgery with carmustine wafers implantation. A long-term
nationwide retrospective study.
World
Neurosurg. 2023 Mar 10:S1878-8750(23)00311-X∟.
doi: 10.1016/j.wneu.2023.03.015∟.
PMID: 36906091∟.
Observational study˰ ˍ
Fuentes-Fayos AC, G-García ME, Pérez-Gómez
JM, Montero-Hidalgo AJ, Martín-Colom J, Doval-Rosa C,
Blanco-Acevedo C, Torres E, Toledano-Delgado Á,
Sánchez-Sánchez R, Peralbo-Santaella E, Ortega-Salas
RM, Jiménez-Vacas JM, Tena-Sempere M, López M,
Castaño JP, Gahete MD, Solivera J, Luque RM.
Metformin
and simvastatin exert additive antitumour effects in glioblastoma
via senescence-state: clinical and translational
evidence.
EBioMedicine.
2023 Mar 10;90:104484∟.
doi: 10.1016/j.ebiom.2023.104484∟.
PMID: 36907105∟.
Laboratory investigation, Observational study. ˍ
He X, Guo Y, Yu C, Zhang H, Wang S.
Epithelial-mesenchymal
transition is the main way in which glioma-associated
microglia/macrophages promote glioma progression.
Front
Immunol. 2023 Mar 10;14:1097880∟.
doi: 10.3389/fimmu.2023.1097880∟.
PMID: 36969175∟.
Laboratory investigation. ˍ
Liu A, Aboud O, Dahabiyeh LA, Bloch O, Fiehn O.
A
pilot study on metabolomic characterization of human glioblastomas
and patient plasma.
Res
Sq [Preprint]. 2023 Mar 10:rs.3.rs-2662020∟.
doi: 10.21203/rs.3.rs-2662020/v1∟.
PMID: 36945517∟.
Interventional study. ˍ
Shiba Y, Motomura K, Taniguchi R, Kurimoto M, Mizutani K, Ohka F,
Aoki K, Ito E, Nishikawa T, Yamaguchi J, Kibe Y, Shimizu H, Maeda
S, Nakashima T, Suzuki H, Muramatsu H, Takahashi Y, Saito
R.
Efficacy and safety of bevacizumab,
irinotecan, and temozolomide combination for relapsed or
refractory pediatric central nervous system embryonal tumor: a
single-institution study.
J
Neurosurg Pediatr. 2023 Mar 10:1-9∟.
doi: 10.3171/2023.1.PEDS22345∟.
PMID: 36905668∟.
Observational study˰ ˍ
Zhu J, Ye J, Dong L, Ma X, Tang N, Xu P, Jin W, Li R, Yang G, Lai
X.
Non-invasive prediction of overall
survival time for glioblastoma multiforme patients based on
multimodal MRI radiomics.
Int
J Imaging Syst Technol. 2023 Mar 10;33(4):1261-1274.
doi:
10.1002/ima.22869. PMID:
38505467. Observational study. ˍ
*
Hou Z, Wu H, Luo N, Li S, Zhang X, Dong S, Zhu D, Zhang H, Tao
R.
Almonertinib Combined with Anlotinib
and Temozolomide in a Patient with Recurrent Glioblastoma with
EGFR L858R Mutation.
Oncologist.
2023 Mar 13:oyac280∟.
doi: 10.1093/oncolo/oyac280∟.
PMID: 36913260∟.
Case report. ˍ
Sharma M, McKenzie GW, Gaskins J, Yusuf M, Woo S, Mistry AM,
Williams BJ.
Demographic variations and
time to initiation of adjunct treatment following surgical
resection of anaplastic astrocytoma in the United States: a
National Cancer Database analysis.
J
Neurooncol. 2023 Mar 13∟.
doi: 10.1007/s11060-023-04286-7?
PMID:
36913046∟.
Observational study˰ ˍ
Zimmermann JSM, Fousse M, Juhasz-Böss I, Radosa JC, Solomayer
EF, Mühl-Benninghaus R.
Neurologic
Consultations and Headache during Pregnancy and in Puerperium: A
Retrospective Chart Review.
J
Clin Med. 2023 Mar 13;12(6):2204∟.
doi: 10.3390/jcm12062204∟.
PMID: 36983206∟.
Observational study. ˍ
Duy Hung N, Duy Linh N, Ha Vi N, Van Anh NT, Dinh Hieu N, Dai Ha
D, Minh Duc N.
Predictive Value of
Preoperative Diffusion Tensor Imaging for Evaluating Postoperative
Outcomes of Supratentorial Glioma in the Motor Function Area.
Ther
Clin Risk Manag. 2023 Mar 14;19:269-278∟.
doi: 10.2147/TCRM.S402622∟.
PMID: 36941979∟.
Observational study. ˍ
Guo X, Shi Y, Liu D, Li Y, Chen W, Wang Y, Wang Y, Xing H, Xia Y,
Li J, Wu J, Liang T, Wang H, Liu Q, Jin S, Qu T, Guo S, Li H, Yang
T, Zhang K, Wang Y, Ma W.
Clinical
updates on gliomas and implications of the 5th edition of the WHO
classification of central nervous system tumors.
Front
Oncol. 2023 Mar 14;13:1131642∟.
doi: 10.3389/fonc.2023.1131642∟.
PMID: 36998447∟.
Observational study. ˍ
Pearl H, Fleischer CC.
Association
between altered metabolism and genetic mutations in human
glioma.
Cancer
Rep (Hoboken). 2023 Mar 14:e1799∟.
doi: 10.1002/cnr2.1799∟.
PMID: 36916606∟.
Laboratory investigation. ˍ
Wu HW, Wu CH, Lin SC, Wu CC, Chen HH, Chen YW, Lee YY, Chang
FC.
MRI features of pediatric atypical
teratoid rhabdoid tumors and medulloblastomas of the posterior
fossa.
Cancer
Med. 2023 Mar 14∟.
doi: 10.1002/cam4.5780∟.
PMID: 36916326∟.
Observational study. ˍ
Bleeker L, Kouwenhoven MCM, de Heer I, Lissenberg-Witte BI,
Gijsbers AH, Dubbink HJ, Kros JM, Gijtenbeek JMM, Kurt E, van der
Rijt CCD, Swaak-Kragten AT, de Vos FY, van der Weide HL, French
PJ, van den Bent MJ, Wesseling P, Bromberg JEC.
Medulloblastoma
in adults: evaluation of the Dutch society for neuro-oncology
treatment protocol.
J
Neurooncol. 2023 Mar 15∟.
doi: 10.1007/s11060-023-04285-8∟.
PMID: 36920679∟.
Observational study. ˍ
Chehade G, Lawson TM, Lelotte J,
Daoud L, Di Perri D, Whenham N, Duprez T, Tajeddine N, Tissir F,
Raftopoulos C.
Long-term
survival in patients with IDH-wildtype glioblastoma: clinical and
molecular characteristics.
Acta
Neurochir (Wien). 2023 Mar 15∟.
doi: 10.1007/s00701-023-05544-3∟.
PMID: 36920664∟.
Observational study˰ ˍ
Sharma M, Do TH, Palzer EF, Huling JD, Chen CC.
Comparable
safety profile between neuro-oncology procedures involving
stereotactic needle biopsy (SNB) followed by laser interstitial
thermal therapy (LITT) and LITT alone procedures.
J
Neurooncol. 2023 Mar 15∟.
doi: 10.1007/s11060-023-04275-w(?). PMID: 36920678∟.
Observational study˰ ˍ